Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels

References

• Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Taube A, Schlich R, Sell H, et al. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012;302:H2148–H2165.
   PubMed Web of Science ®Google Scholar
• Biasucci LM. CDC; AHA. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation. 2004;110:e560–e567.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47:403–411.
   PubMed Web of Science ®Google Scholar
• Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–140.
   PubMed Web of Science ®Google Scholar
• Harutyunyan MJ, Mathiasen AB, Winkel P, et al. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Scand J Clin Lab Invest. 2011;71:52–62.
   PubMed Web of Science ®Google Scholar
• Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease. Scand J Clin Lab Invest. 2009;69:442–446.
   PubMed Web of Science ®Google Scholar
• Ridker PM. A test in context: high-sensitivity C-reactive protein. J Am Coll Cardiol. 2016;67:712–723.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998;98:839–844.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959–1965.
   PubMed Web of Science ®Google Scholar
• Cushman M, Arnold AM, Psaty BM, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation. 2005;112:25–31.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Nyyssönen K, et al. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J. 2005;26:1783–1789.
   PubMed Web of Science ®Google Scholar
• Rogowski O, Vered Y, Shapira I, et al. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta. 2005;358:151–158.
   PubMed Web of Science ®Google Scholar
• Maharshak N, Arbel Y, Gal-Oz A, et al. Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel disease. J Dig Dis. 2008;9:140–143.
   PubMed Web of Science ®Google Scholar
• Grootendorst DC, de Jager DJ, Brandenburg VM, et al. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients–no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant. 2007;22:3277–3284.
   PubMed Web of Science ®Google Scholar
• Kanaan N, Goffin E, Maisin D, et al. CRP measurement: does the assay matter in hemodialysis patients? Clin Nephrol. 2008;70:503–507.
   PubMed Web of Science ®Google Scholar
• Ziv-Baran T, Shenhar-Tsarfaty S, Etz-Hadar I, et al. The ability of the wide range CRP assay to classify individuals with low grade inflammation into cardiovascular risk groups. Clin Chim Acta. 2017;471:185–190.
   PubMed Web of Science ®Google Scholar
• Kendall MG. (1976). Rank correlation methods. 4th edn. London: Charles Griffin.
   Google Scholar
• Davison AC, Hinkley DV. (1997). Bootstrap methods and their application. Cambridge: Cambridge University Press.
   Google Scholar
• Olivieri F, Galeazzi R, Giavarina D, et al. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech Ageing Dev. 2012;133:300–305.
   PubMed Web of Science ®Google Scholar
• Kuster N, Monnier K, Baptista G, et al. Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly. Clin Chem Lab Med. 2015;53:691–698.
   PubMed Web of Science ®Google Scholar
• deFilippi C, Seliger SL, Kelley W, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012;58:1342–1351.
   PubMed Web of Science ®Google Scholar
• Chung JZ, Dallas Jones GR. Effect of renal function on serum cardiac troponin T-population and individual effects. Clin Biochem. 2015;48:807–810.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313:837–846.
   PubMed Web of Science ®Google Scholar
• Arbel Y, Eros Y, Rogowski O, et al. Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography. Am J Cardiol. 2007;99:1504–1506.
   PubMed Web of Science ®Google Scholar
• White GH, Farrance I, AACB Uncertainty of Measurement Working Group. Uncertainty of measurement in quantitative medical testing: a laboratory implementation guide. Clin Biochem Rev. 2004;25:S1–S24.
   PubMedGoogle Scholar
• Matar G, Poggi B, Meley R, et al. Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data. Clin Chem Lab Med. 2015;53:1725–1736.
   PubMed Web of Science ®Google Scholar
• van der Linden N, Klinkenberg LJ, Bekers O, et al. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: a meta-analysis. Medicine (Baltimore). 2016;95:e5703.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503–2512.
   PubMed Web of Science ®Google Scholar
• Hussein AA, Gottdiener JS, Bartz TM, et al. Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the cardiovascular health study. J Am Coll Cardiol. 2013;62:2112–2120.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494–2502.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Al-Shakarchi J, Berglund L, et al. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J. 2013;166:541–548.
   PubMed Web of Science ®Google Scholar
• Oluleye OW, Folsom AR, Nambi V, ARIC Study Investigators, et al. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol. 2013;23:66–73.
   PubMed Web of Science ®Google Scholar
• Shenhar-Tsarfaty S, Ben Assayag E, Bova I, et al. Wide-range C-reactive protein efficacy in acute ischemic stroke patients. Acta Neurol Scand. 2006;114:29–32.
   PubMed Web of Science ®Google Scholar